Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2026-06-22 09:00:05 ET · period of report 2026-06-18 · accession 0001664708-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 09:00 | 2026-06-18 | CRDF | Mohindru Mani | CEO, Dir | P - Purchase | $1.21 | +24.7K | 24.7K | New | +$29.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | P | A | 24,703 | $1.21 | 24,703 | D | — | — |